Guidelines for screening and management of late and long‐term consequences of myeloma and its treatment
John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Abigail Fisher(Department of Health and Social Care), Guy Pratt(Heart of England NHS Foundation Trust), Elaine Boland(Hull and East Yorkshire Hospitals NHS Trust), Kwee Yong(London Cancer), David Greenfield(Sheffield Teaching Hospitals NHS Foundation Trust), Stella Bowcock(King's College Hospital), Jennifer M. Bird(University Hospitals Bristol NHS Foundation Trust), Eric Low(RED Consulting (Norway)), Monica Morris(Myeloma UK)
Cited by 64
Related Papers
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma
|British Journal of Haematology|2004|447
Guidelines for the diagnosis and management of multiple myeloma 2011
|British Journal of Haematology|2011|305
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
|The Lancet Oncology|2021|266